Maxcyte (DI) (MXCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Feb 2021 04:35 PM
RNS
Appointment of Joint Corporate Broker
21 Jan 2021 02:49 PM
RNS
Increase to Block Listing
20 Jan 2021 07:00 AM
RNS
Trading Update
11 Jan 2021 07:00 AM
RNS
Myeloid Therapeutics Clinical & Commercial License
23 Dec 2020 07:00 AM
RNS
Trading Update
09 Nov 2020 01:00 PM
RNS
CARMA Cell Therapies at SITC 2020
09 Nov 2020 07:00 AM
RNS
Presentations at Upcoming Virtual IR Conferences
02 Nov 2020 03:52 PM
RNS
Result of AGM
22 Oct 2020 06:22 PM
RNS
Disclosure of Remuneration for Non-Audit Services
14 Oct 2020 07:00 AM
RNS
Notification of AGM and Audit Declaration
13 Oct 2020 07:00 AM
RNS
MaxCyte announces leadership appointments
01 Oct 2020 07:00 AM
RNS
Director/PDMR Shareholding
21 Sep 2020 07:00 AM
RNS
Results for the Six Months ended 30 June 2020
10 Sep 2020 01:42 PM
RNS
Grant of options
10 Sep 2020 07:00 AM
RNS
HC Wainright & Co Virtual Conference Presentation
09 Sep 2020 07:00 AM
RNS
Appointment of Amanda L. Murphy as CFO
02 Sep 2020 02:57 PM
RNS
Holding(s) in Company
02 Sep 2020 07:00 AM
RNS
Notice of Half Year Results
18 Aug 2020 07:00 AM
RNS
Expansion of CARMA's Phase I Trial of MCY-M11
14 Aug 2020 07:00 AM
RNS
Holding(s) in Company
16 Jul 2020 06:04 PM
RNS
Director Dealings and Issue of Equity
15 Jul 2020 07:00 AM
RNS
Trading Update
08 Jul 2020 07:00 AM
RNS
APEIRON Biologics Clinical and Commercial License
01 Jul 2020 07:00 AM
RNS
Block Listing Return & TVR
02 Jun 2020 05:54 PM
RNS
Holding(s) in Company
28 May 2020 03:34 PM
RNS
Holding(s) in Company
26 May 2020 05:49 PM
RNS
Holding(s) in Company
26 May 2020 04:22 PM
RNS
Holding(s) in Company
26 May 2020 03:45 PM
RNS
Holdings in Company
21 May 2020 01:50 PM
RNS
Result of Special Meeting and Issue of Equity
14 May 2020 07:00 AM
RNS
Poster Presentation on MCY-M11 at ASCO 2020
07 May 2020 07:00 AM
RNS
License Agreement with Caribou Biosciences
01 May 2020 07:00 AM
RNS
Result of Offering
30 Apr 2020 05:39 PM
RNS
Proposed Offering to raise up to £25.1 million
21 Apr 2020 07:00 AM
RNS
Final Results for Year Ended 31 December 2019
09 Apr 2020 07:00 AM
RNS
Business Update Related to COVID-19 Pandemic
24 Mar 2020 07:00 AM
RNS
License Agreement with Allogene Therapeutics
21 Feb 2020 07:00 AM
RNS
Consolidation of Trading Lines
20 Feb 2020 06:18 PM
RNS
AIM Block Admission Return / Total Voting Rights
05 Feb 2020 07:00 AM
RNS
MaxCyte to Present at BIO CEO & Investor Conf
24 Jan 2020 04:31 PM
RNS
Grant Of Options
22 Jan 2020 05:15 PM
RNS
Holding(s) in Company
22 Jan 2020 05:11 PM
RNS
Holding(s) in Company
22 Jan 2020 05:08 PM
RNS
Holding(s) in Company
20 Jan 2020 07:00 AM
RNS
Trading Update
19 Dec 2019 07:00 AM
RNS
New Executive Vice President and Trial Update
16 Dec 2019 05:25 PM
RNS
Director/PCA transaction initial notification
04 Dec 2019 07:00 AM
RNS
Agreement with KSQ Therapeutics
21 Nov 2019 07:00 AM
RNS
Vor Biopharma Clinical and Commercial License
14 Nov 2019 07:00 AM
RNS
Presentation at Jefferies Healthcare Conference
UK 100